TMRW Conference Completed Its Spectacular Debut in Dubai
The Biggest Global Tech Experts Graced the Stages of the Groundbreaking Event Dubai, United Arab…
Year: 2023
ShiftCarbon Releases Carbon Transparency Hub
Vancouver, British Columbia–(Newsfile Corp. – February 13, 2023) – ShiftCarbon (CSE: SHFT) (OTC Pink: SHIFF)…
EC Healthcare Announced Strategic Alliance with Prudential
HONG KONG, Feb 13, 2023 – (ACN Newswire) – EC Healthcare (the “Company”, which together…
Johnson Controls, PURO UV and Ushio Embark on Research to Study the Efficacy and Safety of Filtered Far UV-C technology
This first-of-its-kind Far-UVC research collaboration will evaluate the efficacy of Far-UVC pathogen deactivation while identifying…
FIS Announces Plans to Spin Off Merchant Business
Key facts Planned separation to create two market leading companies with greater strategic flexibility and…
Ault Alliance Announces Record Preliminary 2022 Revenue of $134 Million, up 156% from 2021
Preliminary revenue for the fourth quarter of 2022 of $34.4 million, an increase of 340%…
Henry Schein Announces $400 Million Share Repurchase Plan
MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care products…
iTAC shows how manufacturing can benefit from the Artificial Internet of Things
Montabaur. Combining AI with IoT (AIoT) opens up new potential for creating value from data….
G1 Therapeutics Announces Top Line Results from Pivotal Phase 3 Trial of Trilaciclib in Patients Receiving Triplet Therapy with FOLFOXIRI + Bevacizumab for Metastatic Colorectal Cancer (CRC) (PRESERVE 1)
– PRESERVE 1 Achieved its Co-Primary Endpoints Showing Statistically Significant Reductions in Occurrence of Severe…
Opthea Phase 2b Trial Results of OPT-302 in Combination with Lucentis® for wet AMD Published in the Journal Ophthalmology
MELBOURNE, Australia, Feb. 13, 2023 (GLOBE NEWSWIRE) — Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage…
January 2023’s Most Wanted Malware: Infostealer Vidar Makes a Return while Earth Bogle njRAT Malware Campaign Strikes
Check Point Research reports that infostealer Vidar made its return to the top ten list…
Hypercharge Announces 110 EV Charging Stations at Cressey Development
Vancouver, British Columbia–(Newsfile Corp. – February 13, 2023) – Hypercharge Networks Corp. (NEO: HC) (FSE: PB7)…
Honda Motor Co-founder Takeo Fujisawa to be Inducted into Automotive Hall of Fame
Detroit, Michigan, Feb 13, 2023 – (JCN Newswire) – Takeo Fujisawa, co-founder of the Honda…
Orbital Insight Expands Global Customer Base With Rollout of Recently Launched TerraScope Platform
Company Also Receives New Growth Capital from Existing Investors in Recognition of Recent Contract Wins…
Press Release: Sanofi announces change in R&D leadership
Sanofi announces change in R&D leadership Paris, February 13, 2023. Sanofi announced today that…
LBank Exchange Will List Body Profile (BP) on February 14, 2023
Road Town, British Virgin Islands–(Newsfile Corp. – February 13, 2023) – LBank Exchange, a global…
Adamant Holding Announces Terms for the Closing of Share Purchase Agreement with Europronet d.o.o.
Vancouver, British Columbia–(Newsfile Corp. – February 13, 2023) – Adamant Holding Inc. (CSE: ADMT) (FSE:…
JCB Reaches One Million Rupay JCB Card Issuance Mark in India
TOKYO, Feb 13, 2023 – (JCN Newswire) – JCB International Co., Ltd., the international operations…
Durlston Partners Appoints Meraj Bahram as Managing Partner
LONDON–(BUSINESS WIRE)–Durlston Partners, an expert talent advisory firm specialising in technology, quantitative finance and data…
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., acquires rights to FDA-Approved ELYXYB™ in the U.S. and Canada for the acute treatment of migraine
ELYXYBTM is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute…